Trial redesign for the phase II/III DETECTION trial: circulating tumour DNA-guided therapy for stage IIB/C melanoma after surgical resection

被引：2

作者：

Muinonen-Martin, Andy ^{[1
]}

Lee, Rebecca ^{[2
,3
]}

Rothwell, Dominic ^{[4
]}

Jackson, Richard ^{[5
]}

Smith, Nigel ^{[4
]}

Wong, Stephen ^{[6
,7
]}

Kelso, Noel ^{[4
]}

Hewitt, Chelsee ^{[6
]}

Mitchell, Jackie ^{[4
]}

Jones, Kate ^{[6
]}

Turajlic, Samra ^{[8
]}

Corrie, Pippa ^{[9
]}

Marais, Richard ^{[10
]}

Middleton, Mark ^{[11
]}

Dawson, Sarah-Jane ^{[6
,7
,12
]}

Sandhu, Shahneen ^{[6
,7
]}

Dive, Caroline ^{[4
]}

Lorrigan, Paul ^{[2
]}

机构：

[1] Leeds Teaching Hosp NHS Trust, Leeds, England

[2] Christie NHS Fdn Trust, Manchester, England

[3] Div Canc Sci, Manchester, Lancs, England

[4] Canc Res UK Manchester Inst, Canc Biomarker Ctr, Manchester, Lancs, England

[5] Univ Liverpool, Liverpool Clin Trials Unit, Liverpool, England

[6] Peter MacCallum Canc Ctr, Melbourne, Australia

[7] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Australia

[8] Royal Marsden Hosp, Dept Med Oncol, London, England

[9] Cambridge Univ Hosp NHS Fdn Trust, Cambridge, England

[10] Univ Manchester, Manchester Inst, Mol Oncol Grp, Canc Biomarker Ctr, Manchester, England

[11] Churchill Hosp, Dept Med Oncol, Oxford, England

[12] Univ Melbourne, Ctr Canc Res, Melbourne, Australia

来源：

关键词：

D O I：

10.1093/bjd/ljad113.084

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

P56

引用

页数：1